Viral and inflammatory triggers of neurodegenerative diseases

Science Translational Medicine

Volumn 4, Issue 121, 2012, Pages

  Deleidi, Michela ^a,b,e   Isacson, Ole ^a,b,c,d  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MCLEAN HOSPITAL   (United States)

^c The Harvard Center for Neurodegeneration & Repair   (United States)

^d HARVARD STEM CELL INSTITUTE   (United States)

^e GERMAN CENTER FOR NEURODEGENERATIVE DISEASES DZNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALZHEIMER DISEASE; DEGENERATIVE DISEASE; ENCEPHALITIS; GENETIC SUSCEPTIBILITY; GLIA; HUMAN; HUNTINGTON CHOREA; IMMUNE RESPONSE; INFLUENZA VIRUS A H5N1; JAPANESE ENCEPHALITIS VIRUS; NERVE CELL; NEUROPROTECTION; NONHUMAN; PARKINSON DISEASE; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; BRAIN; IMMUNOLOGY; INFLAMMATION; PATHOLOGY; VIROLOGY;

BRAIN; HUMANS; INFLAMMATION; NEURODEGENERATIVE DISEASES;

EID: 84857225543     PISSN: 19466234     EISSN: 19466242     Source Type: Journal    
DOI: 10.1126/scitranslmed.3003492     Document Type: Review

References (51)

1. S. H. Berth, P. L. Leopold, G. N. Morfini, Virus-induced neuronal dysfunction and degeneration. Front. Biosci. 14, 5239-5259 (2009).
2. R. C. Dale, A. J. Church, R. A. Surtees, A. J. Lees, J. E. Adcock, B. Harding, B. G. Neville, G. Giovannoni, Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity. Brain 127, 21-33 (2004).
3. H. Shoji, M. Watanabe, S. Itoh, H. Kuwahara, F. Hattori, Japanese encephalitis and parkinsonism. J. Neurol. 240, 59-60 (1993).
4. H. Jang, D. Boltz, K. Sturm-Ramirez, K. R. Shepherd, Y. Jiao, R. Webster, R. J. Smeyne, Highly pathogenic H5N1 influenza virus can enter the central nervous system and induce neuroinflammation and neurodegeneration. Proc. Natl. Acad. Sci. U.S.A. 106, 14063-14068 (2009).
5. H. Jang, D. Boltz, J. McClaren, A. K. Pani, M. Smeyne, A. Korff, R. Webster, R. J. Smeyne, Inflammatory effects of highly pathogenic H5N1 influenza virus infection in the CNS of mice. J. Neurosci. 32, 1545-1559 (2012).
6. F. Song, A. Poljak, G. A. Smythe, P. Sachdev, Plasma biomarkers for mild cognitive impairment and Alzheimer's disease. Brain Res. Brain Res. Rev. 61, 69-80 (2009).
7. T. H. Hamza, C. P. Zabetian, A. Tenesa, A. Laederach, J. Montimurro, D. Yearout, D. M. Kay, K. F. Doheny, J. Paschall, E. Pugh, V. I. Kusel, R. Collura, J. Roberts, A. Griffith, A. Samii, W. K. Scott, J. Nutt, S. A. Factor, H. Payami, Common genetic variation in the HLA region is associated with late-onset sporadic Parkinson's disease. Nat. Genet. 42, 781-785 (2010).
8. M. Björkqvist, E. J. Wild, J. Thiele, A. Silvestroni, R. Andre, N. Lahiri, E. Raibon, R. V. Lee, C. L. Benn, D. Soulet, A. Magnusson, B. Woodman, C. Landles, M. A. Pouladi, M. R. Hayden, A. Khalili-Shirazi, M. W. Lowdell, P. Brundin, G. P. Bates, B. R. Leavitt, T. Möller, S. J. Tabrizi, A novel pathogenic pathway of immune activation detectable before clinical onset in Huntington's disease. J. Exp. Med. 205, 1869-1877 (2008).
9. M. Politis, N. Pavese, Y. F. Tai, L. Kiferle, S. L. Mason, D. J. Brooks, S. J. Tabrizi, R. A. Barker, P. Piccini, Microglial activation in regions related to cognitive function predicts disease onset in Huntington's disease: A multimodal imaging study. Hum. Brain Mapp. 32, 258-270 (2011).
10. P. Gannon, M. Z. Khan, D. L. Kolson, Current understanding of HIV-associated neurocognitive disorders pathogenesis. Curr. Opin. Neurol. 24, 275-283 (2011).
11. D. Goldgaber, H. W. Harris, T. Hla, T. Maciag, R. J. Donnelly, J. S. Jacobsen, M. P. Vitek, D. C. Gajdusek, Interleukin 1 regulates synthesis of amyloid beta-protein precursor mRNA in human endothelial cells. Proc. Natl. Acad. Sci. U.S.A. 86, 7606-7610 (1989).
12. I. Blasko, F. Marx, E. Steiner, T. Hartmann, B. Grubeck-Loebenstein, TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J. 13, 63-68 (1999).
13. J. B. Koprich, C. Reske-Nielsen, P. Mithal, O. Isacson, Neuroinflammation mediated by IL-1beta increases susceptibility of dopamine neurons to degeneration in an animal model of Parkinson's disease. J. Neuroinflammation 5, 8 (2008).
14. H. M. Gao, P. T. Kotzbauer, K. Uryu, S. Leight, J. Q. Trojanowski, V. M. Lee, Neuroinflammation and oxidation/nitration of alpha-synuclein linked to dopaminergic neurodegeneration. J. Neurosci. 28, 7687-7698 (2008).
15. T. C. Frank-Cannon, T. Tran, K. A. Ruhn, T. N. Martinez, J. Hong, M. Marvin, M. Hartley, I. Treviño, D. E. O'Brien, B. Casey, M. S. Goldberg, M. G. Tansey, Parkin deficiency increases vulnerability to inflammation-related nigral degeneration. J. Neurosci. 28, 10825-10834 (2008).
16. M. Deleidi, P. J. Hallett, J. B. Koprich, C. Y. Chung, O. Isacson, The Toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration. J. Neurosci. 30, 16091-16101 (2010).
17. M. C. Pott Godoy, R. Tarelli, C. C. Ferrari, M. I. Sarchi, F. J. Pitossi, Central and systemic IL-1 exacerbates neurodegeneration and motor symptoms in a model of Parkinson's disease. Brain 131, 1880-1894 (2008).
18. C. Y. Chung, J. B. Koprich, H. Siddiqi, O. Isacson, Dynamic changes in presynaptic and axonal transport proteins combined with striatal neuroinflammation precede dopaminergic neuronal loss in a rat model of AAV alphasynucleinopathy. J. Neurosci. 29, 3365-3373 (2009).
19. O. Isacson, W. Fischer, K. Wictorin, D. Dawbarn, A. Björklund, Astroglial response in the excitotoxically lesioned neostriatum and its projection areas in the rat. Neuroscience 20, 1043-1056 (1987).
20. A. N. van den Pol, Viral infections in the developing and mature brain. Trends Neurosci. 29, 398-406 (2006).
21. T. Wang, T. Town, L. Alexopoulou, J. F. Anderson, E. Fikrig, R. A. Flavell, Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10, 1366-1373 (2004).
22. M. Bsibsi, R. Ravid, D. Gveric, J. M. van Noort, Broad expression of Toll-like receptors in the human central nervous system. J. Neuropathol. Exp. Neurol. 61, 1013-1021 (2002).
23. M. Weller, A. Stevens, N. Sommer, A. Melms, J. Dichgans, H. Wiethölter, Comparative analysis of cytokine patterns in immunological, infectious, and oncological neurological disorders. J. Neurol. Sci. 104, 215-221 (1991).
24. A. Rösler, M. Pohl, H. J. Braune, W. H. Oertel, D. Gemsa, H. Sprenger, Time course of chemokines in the cerebrospinal fluid and serum during herpes simplex type 1 encephalitis. J. Neurol. Sci. 157, 82-89 (1998).
25. L. M. Boulanger, Immune proteins in brain development and synaptic plasticity. Neuron 64, 93-109 (2009).
26. C. Préhaud, F. Mégret, M. Lafage, M. Lafon, Virus infection switches TLR-3-positive human neurons to become strong producers of beta interferon. J. Virol. 79, 12893-12904 (2005).
27. J. S. Cameron, L. Alexopoulou, J. A. Sloane, A. B. DiBernardo, Y. Ma, B. Kosaras, R. Flavell, S. M. Strittmatter, J. Volpe, R. Sidman, T. Vartanian, Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J. Neurosci. 27, 13033-13041 (2007).
28. Y. Ma, J. Li, I. Chiu, Y. Wang, J. A. Sloane, J. Lü, B. Kosaras, R. L. Sidman, J. J. Volpe, T. Vartanian, Toll-like receptor 8 functions as a negative regulator of neurite outgrowth and inducer of neuronal apoptosis. J. Cell Biol. 175, 209-215 (2006).
29. Y. Ma, R. L. Haynes, R. L. Sidman, T. Vartanian, TLR8: An innate immune receptor in brain, neurons and axons. Cell Cycle 6, 2859-2868 (2007).
30. A. C. Jackson, J. P. Rossiter, M. Lafon, Expression of Toll-like receptor 3 in the human cerebellar cortex in rabies, herpes simplex encephalitis, and other neurological diseases. J. Neurovirol. 12, 229-234 (2006).
31. T. M. Wishart, S. H. Parson, T. H. Gillingwater, Synaptic vulnerability in neurodegenerative disease. J. Neuropathol. Exp. Neurol. 65, 733-739 (2006).
32. D. Centonze, L. Muzio, S. Rossi, F. Cavasinni, V. De Chiara, A. Bergami, A. Musella, M. D'Amelio, V. Cavallucci, A. Martorana, A. Bergamaschi, M. T. Cencioni, A. Diamantini, E. Butti, G. Comi, G. Bernardi, F. Cecconi, L. Battistini, R. Furlan, G. Martino, Inflammation triggers synaptic alteration and degeneration in experimental autoimmune encephalomyelitis. J. Neurosci. 29, 3442-3452 (2009).
33. R. D. Terry, E. Masliah, D. P. Salmon, N. Butters, R. DeTeresa, R. Hill, L. A. Hansen, R. Katzman, Physical basis of cognitive alterations in Alzheimer's disease: Synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580 (1991).
34. C. Holmes, C. Cunningham, E. Zotova, J. Woolford, C. Dean, S. Kerr, D. Culliford, V. H. Perry, Systemic inflammation and disease progression in Alzheimer disease. Neurology 73, 768-774 (2009).
35. C. A. Murray, M. A. Lynch, Evidence that increased hippocampal expression of the cytokine interleukin-1 beta is a common trigger for age- and stress-induced impairments in long-term potentiation. J. Neurosci. 18, 2974-2981 (1998).
36. V. M. Nemani, W. Lu, V. Berge, K. Nakamura, B. Onoa, M. K. Lee, F. A. Chaudhry, R. A. Nicoll, R. H. Edwards, Increased expression of alpha-synuclein reduces neurotransmitter release by inhibiting synaptic vesicle reclustering after endocytosis. Neuron 65, 66-79 (2010).
37. C. S. Savant, B. S. Singhal, J. Jankovic, M. Khan, A. Virani, Substantia nigra lesions in viral encephalitis. Mov. Disord. 18, 213-216 (2003).
38. Y. C. Chen, C. P. Lo, T. P. Chang, Novel influenza A (H1N1)-associated encephalopathy/encephalitis with severe neurological sequelae and unique image features - A case report. J. Neurol. Sci. 298, 110-113 (2010).
39. A. González-Duarte, L. Magaña Zamora, C. Cantú Brito, G. García-Ramos, Hypothalamic abnormalities and Parkinsonism associated with H1N1 influenza infection. J. Neuroinflammation 7, 47 (2010).
40. C. H. Liao, Z. Ling, C. H. Chou, W. S. Huang, J. C. Denq, J. C. Lin, C. Y. Chen, C. J. Chang, G. S. Peng, Involvement of nigrostriatal pathway in Japanese encephalitis with movement disorders: Evidence from 99mTc-TRODAT-1 and 123I-IBZM SPECT imagings. Mol. Imaging Biol. 12, 9-14 (2010).
41. M. D. de Jong, V. C. Bach, T. Q. Phan, M. H. Vo, T. T. Tran, B. H. Nguyen, M. Beld, T. P. Le, H. K. Truong, V. V. Nguyen, T. H. Tran, Q. H. Do, J. Farrar, Fatal avian influenza A (H5N1) in a child presenting with diarrhea followed by coma. N. Engl. J. Med. 352, 686-691 (2005).
42. S. M. Goldman, P. J. Quinlan, G. W. Ross, C. Marras, C. Meng, G. S. Bhudhikanok, K. Comyns, M. Korell, A. R. Chade, M. Kasten, B. Priestley, K. L. Chou, H. H. Fernandez, F. Cambi, J. W. Langston, C. M. Tanner, Solvent exposures and parkinson disease risk in twins. Ann. Neurol. (2011).
43. P. D. Arkwright, M. Abinun, Recently identified factors predisposing children to infectious diseases. Curr. Opin. Infect. Dis. 21, 217-222 (2008).
44. P. I. de Bakker, A. Telenti, Infectious diseases not immune to genome-wide association. Nat. Genet. 42, 731-732 (2010).
45. R. M. Miller, H. J. Federoff, Isoform-specific effects of ApoE on HSV immediate early gene expression and establishment of latency. Neurobiol. Aging 29, 71-77 (2008).
46. Z. Liu, J. Lee, S. Krummey, W. Lu, H. Cai, M. J. Lenardo, The kinase LRRK2 is a regulator of the transcription factor NFAT that modulates the severity of inflammatory bowel disease. Nat. Immunol. 12, 1063-1070 (2011).
47. A. Gardet, Y. Benita, C. Li, B. E. Sands, I. Ballester, C. Stevens, J. R. Korzenik, J. D. Rioux, M. J. Daly, R. J. Xavier, D. K. Podolsky, LRRK2 is involved in the IFN-gamma response and host response to pathogens. J. Immunol. 185, 5577-5585 (2010).
48. M. Hakimi, T. Selvanantham, E. Swinton, R. F. Padmore, Y. Tong, G. Kabbach, K. Venderova, S. E. Girardin, D. E. Bulman, C. R. Scherzer, M. J. LaVoie, D. Gris, D. S. Park, J. B. Angel, J. Shen, D. J. Philpott, M. G. Schlossmacher, Parkinson's disease-linked LRRK2 is expressed in circulating and tissue immune cells and upregulated following recognition of microbial structures. J. Neural Transm. 118, 795-808 (2011).
49. R. D. Abbott, H. Petrovitch, L. R. White, K. H. Masaki, C. M. Tanner, J. D. Curb, A. Grandinetti, P. L. Blanchette, J. S. Popper, G. W. Ross, Frequency of bowel movements and the future risk of Parkinson's disease. Neurology 57, 456-462 (2001).
50. X. Gao, H. Chen, M. A. Schwarzschild, A. Ascherio, A prospective study of bowel movement frequency and risk of Parkinson's disease. Am. J. Epidemiol. 174, 546-551 (2011).
51. D. S. Goldstein, Dysautonomia in Parkinson's disease: Neurocardiological abnormalities. Lancet Neurol. 2, 669-676 (2003).